Details for Patent: 8,034,946
✉ Email this page to a colleague
Summary for Patent: 8,034,946
| Title: | Biphenyl compounds useful as muscarinic receptor antagonists |
| Abstract: | This invention provides compounds of formula I: wherein a, b, c, d, m, n, p, s, t, W, Ar1, R1, R2, R3, R4, R6, R7, and R8 are as defined in the specification. The compounds of formula I are muscarinic receptor antagonists. The invention also provides pharmaceutical compositions containing such compounds, processes and intermediates for preparing such compounds and methods of using such compounds to treat pulmonary disorders. |
| Inventor(s): | Mathai Mammen, YuHua Ji, YongQi Mu, Craig Husfeld, Li Li |
| Assignee: | Theravance Biopharma R&D IP LLC |
| Application Number: | US12/814,629 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent 8,034,946
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,034,946
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 048032 | ⤷ Start Trial | |||
| Argentina | 104444 | ⤷ Start Trial | |||
| Austria | E395335 | ⤷ Start Trial | |||
| Austria | E467617 | ⤷ Start Trial | |||
| Australia | 2005222411 | ⤷ Start Trial | |||
| Brazil | PI0508622 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
